|
[1] Chen F Y, Lee M T, Huang H W. Sigmoidal concentration dependence of antimicrobial peptide activities: A case study on alamethicin. Biophysical Journal, 2002, 82:908-914.
[2] Miyoshi Y, Okada S, Uchimura T, et al. A mucus adhesion promoting protein, MapA, mediates the adhesion of Lactobacillus reuteri to Caco-2 human intestinal epithelial cells. Biosci.Biotechnol.Biochem, 2006, 70(7):1622-1628.
[3] Roos S, Jonsson H. A high-molecular-mass cell-surface protein from Lactocbacillus reuteri 1063 adheres to mucus components. Microbiology, 2002, 148; 433-442.
[4] Caglar E, Topcuoglu N, Cildir S K, et al. Oral colonization by Lactobacillus reuteri ATCC 55730 after exposure to probiotics. Int J Paediatr Dent, 2009, 19(5):377-381.
[5] Bjorkman P J. Colonization of the human gastrointestinal tract by two formulations of Lactobacillus reuteri dissertation. Helsinki, Finland: Univ. of Helsinki, 1999,1025-1035.
[6] Jacobsen C N, Rosenfeldt Nielsen V, Hayford A E, et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol, 1999, 65: 4949-4956.
[7] Ouwehand A C, Conway P L. Purification and characterization of a compound produced by Lactobacillus fermentum that inhibits the adhesion of K88 expressing Escherichia coli to porcine ileal mucus. J Appl Bacteriol, 1996: 311-318.
[8] Axelsson L, Chung T C, Dobrogosz W J, et al. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microbial Ecol Health Dis, 1989, 2: 131-136.
[9] Talarico T L, Dobrogosz W J. Purification and characterization of glycerol dehydratase from Lactobacillus reuteri. Appl Environ Microbiol, 1990, 56: 1195-1197.
[10] Talarico T L, Axelsson L, Novotny J, et al. Utilization of glycerol as a hydrogen acceptor by Lactobacillus reuteri: purification of 1,3-propanediol:NAD oxidoreductase. Appl Environ Microbiol 1990, 56: 943-948.
[11] Talarico T L, Dobrogosz W J. Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri. Antimicrob Agents Chemother, 1989, 33: 674-679.
[12] Tong I T, Cameron D C. Enhancement of 1,3-propanediol production by cofermentation in Escherichia coli expressing Klebsiella pneumonia dha regulon genes. Appl Environ Microbiol, 1992, 34: 149-159.
[13] Spinler J K, Taweechotipatr M, Rognerud C L, et al. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe. 2008, 14(3):166-171.
[14] Dobrogosz W J, Lindgren S E.Method of determining the presence of an antibiotic produced by Lactobacillus reuteri.United States Patent 5352586, October 4,1994.
[15] EI-Ziney N G, Debevere J M. The effect of reuterin on Listeria monocytogenes and Escherichia coli 0157:H7 in milk and cottage cheese. J Food Prot, 1998, 61: 1275-1280.
[16] Dobiogosz W J, Casas I A. Validation of the probiotic concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals. Microbial Ecology in Health and Disease, 2000, 12:247-285.
[17] Gill H S, Rutherfurd K J, Prasad J, et al. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J Nutr, 2000, 83:167-176.
[18] Pessi T, Sutas Y, Hurme M, et al. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy, 2000, 30:1804-1808.
[19] Liu Y, Fatheree N Y, Mangalat N, et al. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastrointest Liver Physiol, 2010, 299: G1087-1096.
[20] Alak J I, Wolf B W, Mdurvwa E G, et al. Effect of Lactobacillus reuteri on intestinal resistance to Cryptosporidium parvum infection in a murine model of acquired immunodeficiency syndrome. J Infect Dis, 1997, 175: 218-221 .
[21] Ungar B L, Kao T C, Burris J A, et al. Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T Iymphocytes in protective immunity. J Immunol, 1991, 147: 1014-1022.
[22] Wu C M, Chung T C, Mice protected by oral immunization with Lactobacillus reuteri secreting fusion protein of Escherichia coli enterotoxin subunit protein. FEMS Immunology Medical Microbiology, 2007, 50(3):354-365.
[23] Madsen K L, Doyle J S, lewell L D, et al. Lactobacillus species prevents colitis in interleukin l0 gene-deficient mice. Gastroenterol, 1999, 116: 1107-1114.
[24] Anukam K C, Hayes K, Summers K, et al. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 may help downregulate TNF-Alpha, IL-6, IL-8, IL-10 and IL-12(p70) in the neurogenic bladder of spinal cord injured patient with urinary tract infections: A Two-Case Study.Advances in Urology,2009,5:1151-1155.
[25] Fabia R, Willen R, Ar'Rajab A, et al. Acetic acid-induced colitis in the rat: a reproducible experimental model for acute ulcerative colitis. Eur Surg Res, 1992, 24: 211-225.
[26] Fabia R, Ar'Rajab A, Johansson M L, et al. Impairrnent of bacterial flora in human ulcerative coiltis and experimental colitis in the rat. Digestion, 1993, 54: 248-255.
[27] Mao Y, Nobaek S, Kasravi B, et al. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterol, 1996, 111: 334-344.
[28] Mao Y, Yu J L, Lungh A, et al. Intestinal immune response to oral administration of Lactobacillus reuteri R2LC, Lactobacillus plantarum DSM 9843, pectin and oatbase on methotrexate-induced enterocolitis in rats. Microbial Ecol Health Dis, 1996, 9: 261-270.
[29] Casas I A, Edens F W, Parkhurst C R, et al. Probiotic administrations of Lactobacillus reuteri moderate avian growth depression in Turkeys. Japan Bifidus foundation, 1998,17(2):125-131.
[30] Dunham H J, Casas I A, Edens F W, et al. Avian growth depression in chickens induced by environmental, microbiological, or nutritional stress is moderated by probiotic administrations of Lactobacillus reuteri. Biosci Microflora, 1998, 17: 133-139.
[31] Dobrogosz W J, Casas I A, Pagano G A, et al. Lactobacillus reuteri and the enteric microbiota. London: Macmillan, 1989: 283-92.
[32] Casas I A, Edens F W, Parkhurst C R, et al. Probiotic treatment with Lactobacillus reuteri protects commerciai turkeys from avian growth depression. Biosci Microflora, 1998, 17: 141-147.
[33] Blanchard P, Gill P, Schulze H. Efficacy of Lactobacillus reuteri 1063-IA in pre and post-weaning pigs. Hertfordshire SG5 4JG (UK): MLC Stotfold Pig Development Unit,1998,9801-9815.
[34] Tazume S, Ozawa A, Yamamoto T. Ecological study on the intestinal bacterial flora of patients with diarrhea. Clin Infect Dis, 1993, 16: 77S-82S .
[35] Romano C, Ferrau V, Cavataio F, et al. Lactobacillus reuteri in children with functional abdominal pain. Journal of Paediatrics and Child Health, 2010,7:1440-1454.
[36] Isolauri E, luntunen M, Rautanen T, et al. A human Lactobacillus strain (Lactobacilllls casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics, 1991, 88: 90-97.
[37] Liu Y Y, Fatheree N Y, Mangalat N, et al. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastrointest Liver Physiol, 2010, 299: G1087-G1096.
[38] Shornikova A V, Casas l A, Isolauri E, et al. Lactobacillus reureri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol, 1997, 24: 399-404.
[39] Shornikova A V, Casas l A, Mykkanen H, et al. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis, 1997, 16:1103-1107.
[40] Coccorullo P, Strisciuglio C, Martinelli M, et al. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: A double-blind, randomized, placebo-controlled Study. J Pediatr, 2010, 157(4):598-602.
[41] Savino F, Cordisco L, Tarasco V, et al. Lactobacillus reuteri DSM 17938 in infantile colic: A randomized, double-blind, placebo-controlled Trial. PEDIATRICS, 2010, 126: e526-e533.
[42] Savino F, Pelle E, Palumeri E, et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) Versus Simethicone in the Treatment of Infantile Colic: A Prospective Randomized Study. Pediatrics, 2007, 119:124-130.
[43] Indrio F, Riezzo G, Raimondi F, et al. Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. Eur J Clin Invest, 2010,41(4):417-422.
|
